TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Long-axis/In-plane and Short-axis/Out-of-plane Methods During the Ultrasound-guided Arterial Cannulation in Pediatric Patients
Brief Summary: Investigators designed a prospective randomized controlled study to compare the long-axis/in-plane and short-axis/out-of-plane methods during the ultrasound-guided arterial catheterization in pediatric patients younger than 5 years old.


Options:
A: Arm Label: Fluoroscopic + Ultrasound Guidance; Type: EXPERIMENTAL; Interventions: Procedure: Fluoroscopic + Ultrasound Guidance | Arm Label: Fluoroscopic Guidance Alone; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Fluoroscopic + Ultrasound Guidance; Assigned to Arm(s): Fluoroscopic + Ultrasound Guidance
B: Arm Label: Infant; Type: EXPERIMENTAL; Interventions: Other: Long-axis/in-plane US-guided arterial catheterization, Other: Short-axis/out-of-plane US-guided arterial catheterization | Arm Label: Preschool child; Type: EXPERIMENTAL; Interventions: Other: Long-axis/in-plane US-guided arterial catheterization, Other: Short-axis/out-of-plane US-guided arterial catheterization | Intervention Type: OTHER; Name: Long-axis/in-plane US-guided arterial catheterization; Assigned to Arm(s): Infant, Preschool child | Intervention Type: OTHER; Name: Short-axis/out-of-plane US-guided arterial catheterization; Assigned to Arm(s): Infant, Preschool child
C: Arm Label: Palpation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Palpation | Arm Label: Ultrasound; Type: EXPERIMENTAL; Interventions: Procedure: Ultrasound guidance | Intervention Type: PROCEDURE; Name: Ultrasound guidance; Assigned to Arm(s): Ultrasound | Intervention Type: PROCEDURE; Name: Palpation; Assigned to Arm(s): Palpation
D: Arm Label: Radial access; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Radial Access | Arm Label: State-of-the-art femoral access; Type: ACTIVE_COMPARATOR; Interventions: Procedure: State-of-the-art femoral access with 18 gauge needle, Procedure: State-of-the-art femoral access with 21 gauge needle | Intervention Type: PROCEDURE; Name: Radial Access; Assigned to Arm(s): Radial access | Intervention Type: PROCEDURE; Name: State-of-the-art femoral access with 18 gauge needle; Assigned to Arm(s): State-of-the-art femoral access | Intervention Type: PROCEDURE; Name: State-of-the-art femoral access with 21 gauge needle; Assigned to Arm(s): State-of-the-art femoral access

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Long-axis/In-plane and Short-axis/Out-of-plane Methods During the Ultrasound-guided Arterial Cannulation in Pediatric Patients
Brief Summary: Investigators designed a prospective randomized controlled study to compare the long-axis/in-plane and short-axis/out-of-plane methods during the ultrasound-guided arterial catheterization in pediatric patients younger than 5 years old.


Options:
A: Arm Label: Palpation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Palpation | Arm Label: Ultrasound; Type: EXPERIMENTAL; Interventions: Procedure: Ultrasound guidance | Intervention Type: PROCEDURE; Name: Ultrasound guidance; Assigned to Arm(s): Ultrasound | Intervention Type: PROCEDURE; Name: Palpation; Assigned to Arm(s): Palpation
B: Arm Label: Infant; Type: EXPERIMENTAL; Interventions: Other: Long-axis/in-plane US-guided arterial catheterization, Other: Short-axis/out-of-plane US-guided arterial catheterization | Arm Label: Preschool child; Type: EXPERIMENTAL; Interventions: Other: Long-axis/in-plane US-guided arterial catheterization, Other: Short-axis/out-of-plane US-guided arterial catheterization | Intervention Type: OTHER; Name: Long-axis/in-plane US-guided arterial catheterization; Assigned to Arm(s): Infant, Preschool child | Intervention Type: OTHER; Name: Short-axis/out-of-plane US-guided arterial catheterization; Assigned to Arm(s): Infant, Preschool child
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Ultrasound; Type: EXPERIMENTAL; Interventions: Device: Real-time Ultrasound Guidance (Site-Rite 5 or 6 machine) | Intervention Type: DEVICE; Name: Real-time Ultrasound Guidance (Site-Rite 5 or 6 machine); Assigned to Arm(s): Ultrasound
D: Arm Label: CAIG; Type: EXPERIMENTAL; Interventions: Device: Computer Assisted Instrument Guidance (CAIG), which supplements existing ultrasound capabilities. | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Computer Assisted Instrument Guidance (CAIG), which supplements existing ultrasound capabilities.; Assigned to Arm(s): CAIG

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 3 Open-label Trial Assessing the Safety and Efficacy of Bedaquiline Plus PA-824 Plus Linezolid in Subjects With Pulmonary Infection of Either Extensively Drug-resistant Tuberculosis (XDR-TB) or Treatment Intolerant / Non-responsive Multi-drug Resistant Tuberculosis (MDR-TB).
Brief Summary: The purpose of this study is to evaluate the efficacy, safety, tolerability and pharmacokinetics of bedaquiline plus PA-824 plus linezolid after 6 months of treatment (option for 9 months for participants who remain culture positive at month 4) in participants with either pulmonary extensively drug resistant tuberculosis (XDR-TB), treatment intolerant or non-responsive multi-drug resistant tuberculosis (MDR-TB).


Options:
A: Arm Label: Intervention; Type: OTHER; Interventions: Diagnostic Test: LF-LAM | Arm Label: Standard of care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIAGNOSTIC_TEST; Name: LF-LAM; Assigned to Arm(s): Intervention
B: Arm Label: Case Detection Group; Type: N/A; Interventions: Diagnostic Test: Truenat MTB | Arm Label: Drug Resistant TB Group; Type: N/A; Interventions: Diagnostic Test: Truenat MTB | Intervention Type: DIAGNOSTIC_TEST; Name: Truenat MTB; Assigned to Arm(s): Case Detection Group, Drug Resistant TB Group
C: Arm Label: Bedaquiline + PA-824 + Linezolid; Type: EXPERIMENTAL; Interventions: Drug: Bedaquiline, Drug: PA-824, Drug: Linezolid | Intervention Type: DRUG; Name: Bedaquiline; Assigned to Arm(s): Bedaquiline + PA-824 + Linezolid | Intervention Type: DRUG; Name: PA-824; Assigned to Arm(s): Bedaquiline + PA-824 + Linezolid | Intervention Type: DRUG; Name: Linezolid; Assigned to Arm(s): Bedaquiline + PA-824 + Linezolid
D: Intervention Type: OTHER; Name: No Intervention; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Mental Health First-Aid Training in Denmark. A Randomized Controlled Trial With a Six-Month Follow-Up Supplemented With a Qualitative Study
Brief Summary: The purpose of the study is evaluate the effect of the Mental Health First-aid training course on a Danish population of employees.


Options:
A: Arm Label: Pure control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention residence on mixed campus; Type: EXPERIMENTAL; Interventions: Behavioral: Mental Health First Aid | Arm Label: Pure intervention residence; Type: EXPERIMENTAL; Interventions: Behavioral: Mental Health First Aid | Arm Label: Control at mixed campus; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mental Health First Aid; Assigned to Arm(s): Intervention residence on mixed campus, Pure intervention residence
B: Arm Label: Mental Health First Aid Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Mental Health First Aid | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mental Health First Aid; Assigned to Arm(s): Mental Health First Aid Intervention
C: Arm Label: Contact-based mental health education; Type: EXPERIMENTAL; Interventions: Behavioral: Beyond Silence | Arm Label: Mental health literacy training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mental Health First Aid (MHFA) | Intervention Type: BEHAVIORAL; Name: Beyond Silence; Assigned to Arm(s): Contact-based mental health education | Intervention Type: BEHAVIORAL; Name: Mental Health First Aid (MHFA); Assigned to Arm(s): Mental health literacy training
D: Arm Label: Training course; Type: EXPERIMENTAL; Interventions: Other: Mental Health First-aid | Arm Label: Waiting list; Type: OTHER; Interventions: Other: Mental Health First-aid | Intervention Type: OTHER; Name: Mental Health First-aid; Assigned to Arm(s): Training course, Waiting list

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Trial of Interim Methadone and Patient Navigation Initiated in Jail
Brief Summary: The purpose of this study is to determine which of three approaches started in jail is more effective in treating opioid use disorder: (1) methadone treatment without counseling (termed interim methadone) coupled with case management (termed patient navigation); (2) interim methadone without patient navigation; (3) or an enhanced treatment as usual including opioid detoxification, overdose prevention and drug treatment information and referral.


Options:
A: Arm Label: Methadone plus Patient Navigation; Type: EXPERIMENTAL; Interventions: Drug: Methadone, Behavioral: Patient Navigation | Arm Label: Methadone; Type: EXPERIMENTAL; Interventions: Drug: Methadone | Arm Label: Enhanced Treatment as Usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced Treatment as Usual (ETAU) | Intervention Type: DRUG; Name: Methadone; Assigned to Arm(s): Methadone, Methadone plus Patient Navigation | Intervention Type: BEHAVIORAL; Name: Patient Navigation; Assigned to Arm(s): Methadone plus Patient Navigation | Intervention Type: BEHAVIORAL; Name: Enhanced Treatment as Usual (ETAU); Assigned to Arm(s): Enhanced Treatment as Usual
B: Arm Label: Vivitrol at place of residence; Type: EXPERIMENTAL; Interventions: Drug: XR-NTX, Other: place of residence | Arm Label: Vivitrol at opioid treatment program; Type: ACTIVE_COMPARATOR; Interventions: Drug: XR-NTX, Other: opioid treatment program | Intervention Type: DRUG; Name: XR-NTX; Assigned to Arm(s): Vivitrol at opioid treatment program, Vivitrol at place of residence | Intervention Type: OTHER; Name: place of residence; Assigned to Arm(s): Vivitrol at place of residence | Intervention Type: OTHER; Name: opioid treatment program; Assigned to Arm(s): Vivitrol at opioid treatment program
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Core; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Core | Arm Label: Enhanced; Type: EXPERIMENTAL; Interventions: Behavioral: Core, Behavioral: Enhanced | Intervention Type: BEHAVIORAL; Name: Core; Assigned to Arm(s): Core, Enhanced | Intervention Type: BEHAVIORAL; Name: Enhanced; Assigned to Arm(s): Enhanced
D: Arm Label: Motivational Interviewing; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interviewing | Arm Label: Supervision As Usual; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Motivational Computer; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Computer | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing; Assigned to Arm(s): Motivational Interviewing | Intervention Type: BEHAVIORAL; Name: Motivational Computer; Assigned to Arm(s): Motivational Computer

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Bump on the Ball: Impact of a Prenatal Exercise & Education Program on Birth Outcomes & Maternal Quality of Life
Brief Summary: Operative vaginal delivery (with forceps or vacuums) is frequently performed secondary to maternal exhaustion, which leads to an inability to push effectively; 40% of operative vaginal deliveries at Prentice are for maternal exhaustion. The risk of severe birth trauma is increased three to four fold with operative delivery. This randomized, controlled trial will compare rates of operative vaginal delivery and severe birth trauma in two groups of women: (1) an intervention group who will participate in the antepartum Total Control® fitness and education program modified for pregnancy; and (2) a control group. Women will be recruited and followed from the second trimester until 6 weeks postpartum; all will complete validated questionnaires regarding their (1) level of worry and knowledge about their birthing experience (2) pelvic floor symptoms and quality of life (3) sexual function (4) satisfaction with their birthing experience and (5) level of depressive symptoms at various time points during and after their pregnancy. Obstetrical data will also be collected.


Options:
A: Arm Label: Pelvic floor training; Type: ACTIVE_COMPARATOR; Interventions: Other: Pelvic floor training | Arm Label: Literature-only group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Pelvic floor training; Assigned to Arm(s): Pelvic floor training
B: Arm Label: Exercise group; Type: EXPERIMENTAL; Interventions: Other: Exercise classes with pelvic floor muscle training | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Exercise classes with pelvic floor muscle training; Assigned to Arm(s): Exercise group
C: Arm Label: Study group - Treatment with PFFM; Type: EXPERIMENTAL; Interventions: Procedure: Pelvic floor fascial mobilization | Arm Label: Control group -; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Pelvic floor fascial mobilization; Assigned to Arm(s): Study group - Treatment with PFFM
D: Arm Label: Total Control Program; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Total Control Program | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Total Control Program; Assigned to Arm(s): Total Control Program

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tranexamic Acid in Major Vascular Surgery. A Randomized Placebo-controlled Trial.
Brief Summary: The purpose of this study is to determine whether tranexamic acid is effective in reducing intraoperative blood loss and necessity for haemotransfusion in patients undergoing open abdominal aortic aneurysm repair


Options:
A: Arm Label: Tranexamic Acid; Type: EXPERIMENTAL; Interventions: Drug: tranexamic acid diluted in 100 ml of saline solution (loading dose), Drug: tranexamic acid undiluted (continous infusion) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: tranexamic acid diluted in 100 ml of saline solution (loading dose); Assigned to Arm(s): Tranexamic Acid | Intervention Type: DRUG; Name: tranexamic acid undiluted (continous infusion); Assigned to Arm(s): Tranexamic Acid | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Intervention Type: DRUG; Name: Human Thrombin; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Bovine Thrombin; Assigned to Arm(s): N/A
C: Intervention Type: DRUG; Name: Fibrin sealant (FS2); Assigned to Arm(s): N/A
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Biological: rThrombin | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: bovine thrombin | Intervention Type: BIOLOGICAL; Name: rThrombin; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: bovine thrombin; Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Single Incision Transumbilical Laparoscopic Varicocelectomy: Comparison With the Conventional Laparoscopic Approach.
Brief Summary: Conventional laparoscopic varicocelectomy using 3 ports has been used for treatment of varicocele in our department since the nineties. However, the relatively several trocar wounds represent a big challenge against its acceptance by many of our patients who prefer the open approach with one or at least two wounds.

Single incision laparoscopic surgery (SILS), since its introduction in 2007, has been proven to be feasible and effective, with high patient satisfaction rates regarding improved cosmotic outcomes, reduced postoperative pain, and rapid return to normal activities. (10, 11) SILS for varicocelectomy has been reported to be safe and effective alternative to conventional laparoscopic varicocelectomy in a few studies.


Options:
A: Arm Label: SIL-V; Type: ACTIVE_COMPARATOR; Interventions: Procedure: single incision laparoscopic varicocelectomy | Arm Label: CTL-V; Type: ACTIVE_COMPARATOR; Interventions: Procedure: conventional transperitoneal laparoscopic varicocelectomy | Intervention Type: PROCEDURE; Name: single incision laparoscopic varicocelectomy; Assigned to Arm(s): SIL-V | Intervention Type: PROCEDURE; Name: conventional transperitoneal laparoscopic varicocelectomy; Assigned to Arm(s): CTL-V
B: Arm Label: Group 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: SILS cholecystectomy | Arm Label: Group 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: TPCL cholecystectomy | Intervention Type: PROCEDURE; Name: SILS cholecystectomy; Assigned to Arm(s): Group 1 | Intervention Type: PROCEDURE; Name: TPCL cholecystectomy; Assigned to Arm(s): Group 2
C: Arm Label: Single port laparoscopic device; Type: EXPERIMENTAL; Interventions: Device: Single port laparoscopic cholecystectomy SINGLE SITE LAPAROSCOPY ACCESS SYSTEM (Johnson & Johnson Medical Spa) | Arm Label: Four-port laparoscopic device; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Four port laparoscopic cholecystectomy surgery | Intervention Type: DEVICE; Name: Single port laparoscopic cholecystectomy SINGLE SITE LAPAROSCOPY ACCESS SYSTEM (Johnson & Johnson Medical Spa); Assigned to Arm(s): Single port laparoscopic device | Intervention Type: PROCEDURE; Name: Four port laparoscopic cholecystectomy surgery; Assigned to Arm(s): Four-port laparoscopic device
D: Arm Label: SILS appendectomy; Type: EXPERIMENTAL; Interventions: Procedure: SILS appendectomy | Arm Label: Conventional laparoscopic appendectomy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: conventional laparoscopic appendectomy | Intervention Type: PROCEDURE; Name: SILS appendectomy; Assigned to Arm(s): SILS appendectomy | Intervention Type: PROCEDURE; Name: conventional laparoscopic appendectomy; Assigned to Arm(s): Conventional laparoscopic appendectomy

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase II Clinical Trial of Pembrolizumab (MK-3475) in Subjects With Advanced/Unresectable or Metastatic Urothelial Cancer
Brief Summary: This is a study using pembrolizumab (MK-3475, KEYTRUDA®) for first-line treatment of participants with advanced/unresectable (inoperable) or metastatic urothelial cancer who are ineligible for cisplatin-based therapy. The primary study objective is to determine the objective response rate (ORR) in all participants and by programmed cell death ligand 1 (PD-L1) status.

With Amendment 4, once a participant has achieved the study objective or the study has ended, the participant will be discontinued from this study and will be enrolled in an extension study to continue protocol-defined assessments and treatment.


Options:
A: Arm Label: Control Arm A; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: Experimental Arm B; Type: EXPERIMENTAL; Interventions: Drug: Pembrolizumab | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Control Arm A | Intervention Type: DRUG; Name: Pembrolizumab; Assigned to Arm(s): Experimental Arm B
B: Arm Label: Pembrolizumab; Type: EXPERIMENTAL; Interventions: Biological: pembrolizumab | Intervention Type: BIOLOGICAL; Name: pembrolizumab; Assigned to Arm(s): Pembrolizumab
C: Arm Label: Pembrolizumab + ST Chemotherapy (Pembro Combo); Type: EXPERIMENTAL; Interventions: Biological: Pembrolizumab, Drug: Cisplatin, Drug: Carboplatin, Drug: Gemcitabine | Arm Label: Pembrolizumab (Pembro); Type: EXPERIMENTAL; Interventions: Biological: Pembrolizumab | Arm Label: ST Chemotherapy (Chemo); Type: ACTIVE_COMPARATOR; Interventions: Drug: Cisplatin, Drug: Carboplatin, Drug: Gemcitabine | Intervention Type: BIOLOGICAL; Name: Pembrolizumab; Assigned to Arm(s): Pembrolizumab (Pembro), Pembrolizumab + ST Chemotherapy (Pembro Combo) | Intervention Type: DRUG; Name: Cisplatin; Assigned to Arm(s): Pembrolizumab + ST Chemotherapy (Pembro Combo), ST Chemotherapy (Chemo) | Intervention Type: DRUG; Name: Carboplatin; Assigned to Arm(s): Pembrolizumab + ST Chemotherapy (Pembro Combo), ST Chemotherapy (Chemo) | Intervention Type: DRUG; Name: Gemcitabine; Assigned to Arm(s): Pembrolizumab + ST Chemotherapy (Pembro Combo), ST Chemotherapy (Chemo)
D: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Drug: paclitaxel, Drug: vinflunine, Drug: docetaxel | Arm Label: Pembrolizumab; Type: EXPERIMENTAL; Interventions: Biological: pembrolizumab | Intervention Type: BIOLOGICAL; Name: pembrolizumab; Assigned to Arm(s): Pembrolizumab | Intervention Type: DRUG; Name: paclitaxel; Assigned to Arm(s): Control | Intervention Type: DRUG; Name: vinflunine; Assigned to Arm(s): Control | Intervention Type: DRUG; Name: docetaxel; Assigned to Arm(s): Control

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multimedia Internet-Based Program for Workers With Subthreshold Depression
Brief Summary: Depression is one of the most prevalent mental disorders to afflict adults. It seriously impacts role functioning and often takes a recurrent or chronic course. Because most adults who suffer from depression never receive treatment, there is a critical need to develop interventions that can be easily implemented and widely disseminated. Interventions that reduce the performance-impairing symptoms of subclinical depression and prevent the onset of major depression can improve employee well-being, while reducing healthcare costs and improving productivity. This project produced a mobile-web program to activate cognitive behavioral skills in workers with subthreshold depression, reduce depression symptoms, improve functioning in the workplace, and potentially reduce the risk for escalation to full-syndrome depression.


Options:
A: Arm Label: MoodHacker; Type: EXPERIMENTAL; Interventions: Behavioral: MoodHacker | Arm Label: Alternative Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Alternative Care | Intervention Type: BEHAVIORAL; Name: MoodHacker; Assigned to Arm(s): MoodHacker | Intervention Type: BEHAVIORAL; Name: Alternative Care; Assigned to Arm(s): Alternative Care
B: Arm Label: Be Well At Work intervention + IC; Type: EXPERIMENTAL; Interventions: Other: Veterans Work and Health Initiative | Arm Label: Integrated Care Only; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Veterans Work and Health Initiative; Assigned to Arm(s): Be Well At Work intervention + IC
C: Arm Label: WHI; Type: EXPERIMENTAL; Interventions: Behavioral: Work and Health Initiative | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Medical or Behavioral Intervention | Intervention Type: BEHAVIORAL; Name: Work and Health Initiative; Assigned to Arm(s): WHI | Intervention Type: BEHAVIORAL; Name: Usual Medical or Behavioral Intervention; Assigned to Arm(s): Usual Care
D: Intervention Type: DRUG; Name: DVS-233 SR; Assigned to Arm(s): N/A

Answer: A